149th ENMC International Workshop and 1st TREAT-NMD Workshop on: "planning phase i/ii clinical trials using systemically delivered antisense oligonucleotides in duchenne muscular dystrophy".

Source:http://linkedlifedata.com/resource/pubmed/id/18207401

Download in:

View as

General Info

PMID
18207401